HEARTBEAM, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
HEARTBEAM, INC. (BEAT) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $1.37 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-08-13
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2026-03-31 was $1.45, a 36.68% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $2.29.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $4.00, a 109.42% increase year-over-year.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $1.66, a 29.66% decline from fiscal 2024.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $2.36, a 2.48% decline from fiscal 2023.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $2.42, a 42.35% increase from fiscal 2022.
- HEARTBEAM, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $1.70, a 47.20% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.37 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | $1.45 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $1.66 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $1.68 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $1.69 10-Q · filed 2025-08-13 | |||
| 2025-03-31 | $2.29 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | $2.36 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $2.32 10-Q · filed 2024-11-07 | |||
| 2024-06-30 | $2.27 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | |||
| 2023-12-31 | $2.42 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $2.80 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $2.62 10-Q · filed 2023-08-10 | |||
| 2023-03-31 | $4.00 10-Q · filed 2023-05-11 | |||
| 2022-12-31 | $1.70 10-K · filed 2024-03-20 | |||
| 2022-09-30 | $1.44 10-Q · filed 2022-11-10 | |||
| 2022-06-30 | $1.39 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $1.91 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $3.22 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $2.30 10-Q · filed 2021-12-16 | |||
| 2020-12-31 | $0.28 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |